Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)

Martin Clodi; Heidemarie Abrahamian; Helmut Brath; Guntram Schernthaner; Johann Brix; Bernhard Ludvik; Heinz Drexel; Christoph H Saely; Peter Fasching; Gersina Rega-Kaun; Bernhard Föger; Claudia Francesconi; Elke Fröhlich-Reiterer; Alexandra Kautzky-Willer; Jürgen Harreiter; Anton Luger; Michael Resl; Michaela Riedl; Yvonne Winhofer; Sabine E Hofer; Friedrich Hoppichler; Joakim Huber; Susanne Kaser; Claudia Ress; Monika Lechleitner; Felix Aberer; Julia K Mader; Harald Sourij; Hermann Toplak; Bernhard Paulweber; Lars Stechemesser; Thomas Pieber; Rudolf Prager; Harald Stingl; Thomas Stulnig; Birgit Rami-Merhar; Michael Roden; Christian Schelkshorn; Thomas C Wascher; Raimund Weitgasser; Sandra Zlamal-Fortunat

doi:10.1007/s00508-023-02186-4

Back

Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)

Journal article

Open access

Peer reviewed

Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)

Martin Clodi, Heidemarie Abrahamian, Helmut Brath, Guntram Schernthaner, Johann Brix, Bernhard Ludvik, Heinz Drexel, Christoph H Saely, Peter Fasching, Gersina Rega-Kaun, …

Wiener Klinische Wochenschrift, v 135(Suppl 1), pp 32-44

Jan 2023

DOI: https://doi.org/10.1007/s00508-023-02186-4

PMID: 37101023

Featured in Collection : UN Sustainable Development Goals @ Drexel

Files and links (1)

url

https://doi.org/10.1007/s00508-023-02186-4View

Published, Version of Record (VoR) Open

Abstract

Blood Glucose

Diabetes Mellitus, Type 2 - complications

Diabetes Mellitus, Type 2 - diagnosis

Diabetes Mellitus, Type 2 - drug therapy

Humans

Hyperglycemia - drug therapy

Hypoglycemic Agents - therapeutic use

Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety as well as cardiovascular effects is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.

Metrics

6 Record Views

3 citations in Web of Science

3 citations in Scopus

Details

Title: Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)
Creators: Martin Clodi - Johannes Kepler University of Linz
Heidemarie Abrahamian - Privates Institut für Medizin & NLP, Wissenschaftliches Institut gemäß BundesstatistikG 2008 ÖNACE-CODE: 72.19-0, Wien, Österreich
Helmut Brath - Sigmund Freud Privatuniversität Wien
Guntram Schernthaner - Universität Wien, Wien, Österreich
Johann Brix - Krankenanstalt Rudolfstiftung der Stadt Wien
Bernhard Ludvik - Krankenanstalt Rudolfstiftung der Stadt Wien
Heinz Drexel - Vorarlberg Institute for Vascular Investigation and Treatment
Christoph H Saely - Vorarlberg Institute for Vascular Investigation and Treatment
Peter Fasching - Wilhelminen Hospital
Gersina Rega-Kaun - Wilhelminen Hospital
Bernhard Föger - Abteilung für Allgemein Innere Medizin, Rottal Inn Kliniken, Pfarrkirchen, Deutschland
Claudia Francesconi - Sonderkrankenanstalt Rehabilitationszentrum Alland, Alland, Österreich
Elke Fröhlich-Reiterer - Medical University of Graz
Alexandra Kautzky-Willer - Medical University of Vienna
Jürgen Harreiter - Medical University of Vienna
Anton Luger - Medical University of Vienna
Michael Resl - Convent Hospital of the Brothers of Saint John of God
Michaela Riedl - Medical University of Vienna
Yvonne Winhofer - Medical University of Vienna
Sabine E Hofer - Innsbruck Medical University
Friedrich Hoppichler - Ordensklinikum Linz Barmherzige Schwestern
Joakim Huber - Interne Abteilung mit Akutgeriatrie und Palliativmedizin, Franziskus Spital, Standort Landstraße, Wien, Österreich
Susanne Kaser - Innsbruck Medical University
Claudia Ress - Innsbruck Medical University
Monika Lechleitner - Avomed - Arbeitskreis für Vorsorgemedizin zbd Gesundheitsförderung in Tirol, Innsbruck, Österreich
Felix Aberer - Medical University of Graz
Julia K Mader - Medical University of Graz
Harald Sourij - Klinische Abteilung für Endokrinologie und Diabetologie, Universitätsklinik für Innere Medizin, Medizinische Universität Graz, Graz, Österreich
Hermann Toplak - Medical University of Graz
Bernhard Paulweber - Paracelsus Medizinische Privatuniversität
Lars Stechemesser - Paracelsus Medizinische Privatuniversität
Thomas Pieber - Medical University of Graz
Rudolf Prager - Karl Landsteiner University of Health Sciences
Harald Stingl - Karl Landsteiner University of Health Sciences
Thomas Stulnig - Klinik Hietzing
Birgit Rami-Merhar - Medical University of Vienna
Heinz Drexel - Drexel University
Michael Roden - Institut für Klinische Diabetologie, Deutsches Diabetes-Zentrum (DDZ), Leibniz-Zentrum für Diabetesforschung, Düsseldorf, Deutschland
Christian Schelkshorn - Landesklinikum Korneuburg
Thomas C Wascher - Hanusch Hospital
Raimund Weitgasser - Universitätsklinik für Innere Medizin I, LKH Salzburg - Universitätsklinikum der Paracelsus Medizinischen Privatuniversität, Salzburg, Österreich
Sandra Zlamal-Fortunat - Klinikum Klagenfurt
Publication Details: Wiener Klinische Wochenschrift, v 135(Suppl 1), pp 32-44
Publisher: Springer Nature
Resource Type: Journal article
Language: German
Academic Unit: College of Medicine
Web of Science ID: WOS:000989534600004
Scopus ID: 2-s2.0-85153918990
Other Identifier: 991021860616604721

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Domestic collaboration; International collaboration
Web of Science research areas: Endocrinology & Metabolism